What bothers me about this announcement is that the science team has been distracted for six months (which is what it takes to rebuild the library) instead of focusing on actually producing "hits" or useable drugs from the current libraries! Sure, there's always a greener paddock out there somewhere, but from a commercial perspective, PYC just needs to use what it already has! Where is the CD40L program at?? What's happening with the Roche program??
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
0.030(2.21%) |
Mkt cap ! $810.7M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.39 | $1.33 | $103.4K | 75.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2600 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 14999 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |